Benzodiazepine use in the real world of psychiatric practice: Low-dose, long-term drug taking and low rates of treatment discontinuation

European Journal of Clinical Pharmacology

Volumn 63, Issue 9, 2007, Pages 867-873

  Veronese, Antonio ^a   Garatti, Massimo ^a   Cipriani, Andrea ^a   Barbui, Corrado ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Affective illness; Benzodiazipene; Long term treatment

Indexed keywords

ALPRAZOLAM; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; DELORAZEPAM; DIAZEPAM; LITHIUM; LORAZEPAM; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CLINICAL PRACTICE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG EXPOSURE; DRUG USE; DRUG WITHDRAWAL; EDUCATION; FEMALE; HEALTH CARE UTILIZATION; HUMAN; ITALY; LONGITUDINAL STUDY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERSONALITY DISORDER; PRIORITY JOURNAL; PROBABILITY; PROPORTIONAL HAZARDS MODEL; PSYCHIATRY; PSYCHOSIS; RETROSPECTIVE STUDY; TREATMENT DURATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BENZODIAZEPINES; COMMUNITY MENTAL HEALTH CENTERS; COMMUNITY MENTAL HEALTH SERVICES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; PSYCHIATRY; TIME FACTORS; TREATMENT REFUSAL;

EID: 34547807708     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-007-0341-1     Document Type: Article

References (25)

1. Divac N, Veljkovic S, Nesic Z, Stojanovic R, Bajcetic M, Vasiljevic Z, Prostran M, Samardzic R (2006) Pattern of utilization of benzodiazepines in patients with hypertension: a pilot study. Vojnosanit Pregl 63:370-375
2. Gorgels WJ, Oude Voshaar RC, Mol AJ, van de Lisdonk EH, van Balkom AJ, Breteler MH, van den Hoogen HJ, Mulder J, Zitman FG (2006) Predictors of discontinuation of benzodiazepine prescription after sending a letter to long-term benzodiazepine users in family practice. Fam Pract 23:65-72
3. De las Cuevas C, Sanz E, De La Fuente JA, Cabrera C, Mateos A (1999) Prescribed daily doses and 'risk factors' associated with the use of benzodiazepines in primary care. Pharmacoepidemiol Drug Saf 8:207-216
4. van HR, Isacson D, Bakker A, Leufkens HG (2003) Comparing patterns of long-term benzodiazepine use between a Dutch and a Swedish community. Pharmacoepidemiol Drug Saf 12:49-53
5. van HR, Leufkens HG, Bakker A (1998) Usage patterns of benzodiazepines in a Dutch community: a 10-year follow-up. Pharm World Sci 20:78-82
6. Clark RE, Xie H, Brunette MF (2004) Benzodiazepine prescription practices and substance abuse in persons with severe mental illness. J Clin Psychiatry 65:151-155
7. Brunette MF, Noordsy DL, Xie H, Drake RE (2003) Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders. Psychiatr Serv 54:1395-1401
8. Tansella M, Amaddeo F, Burti L, Lasalvia A, Ruggeri M (2006) Evaluating a community-based mental health service focusing on severe mental illness. The Verona experience. Acta Psychiatr Scand Suppl 429:90-94
9. Tansella M, Burti L (2003) Integrating evaluative research and community-based mental health care in Verona, Italy. Br J Psychiatry 183:167-169
10. Amaddeo F, Beecham J, Bonizzato P, Fenyo A, Knapp M, Tansella M (1997) The use of a case register to evaluate the costs of psychiatric care. Acta Psychiatr Scand 95:189-198
11. Barbui C, Nosè M, Rambaldelli G, Bonetto C, Levi D, Patten S, Tansella M (2005) Development of a registry for monitoring psychotropic drug prescriptions: aims, methods and implications for ordinary practice and research. Int J Methods Psych Res 14:151-157
12. Lavik NJ (1983) Utilization of mental health services over a given period. Acta Psychiatr Scand 67:404-413
13. Bonetto C, Nose M, Barbui C (2006) Generating drug exposure data from computer-based medical records. Comput Methods Programs Biomed 83:120-124
14. Roy-Byrne PP, Hommer D (1988) Benzodiazepine withdrawal: overview and implications for the treatment of anxiety. Am J Med 84:1041-1052
15. WHO Collaborating Centre for Drug Statistic Methodology (2003) Guidelines for ATC classification and DDD assignment. WHO, Oslo
16. Jones G (2003) Prescribing and taking medicines. BMJ 327:819
17. Committee on the Review of Medicines (1980) Systematic review of the benzodiazepines. Guidelines for data sheets on diazepam, chlordiazepoxide, medazepam, clorazepate, lorazepam, oxazepam, temazepam, triazolam, nitrazepam, and flurazepam. Br Med J 280:910-912
18. American Psychiatric Association Task Force on Benzodiazepine Dependency (1990) Benzodiazepine dependence. Toxicity and abuse. American Psychiatric Association, Washington DC
19. Pollack MH, Otto MW, Tesar GE, Cohen LS, Meltzer-Brody S, Rosenbaum JF (1993) Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder. J Clin Psychopharmacol 13:257-263
20. Worthington JJ, III, Pollack MH, Otto MW, McLean RY, Moroz G, Rosenbaum JF (1998) Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder. Psychopharmacol Bull 34:199-205
21. O'Brien CP (2005) Benzodiazepine use, abuse, and dependence. J Clin Psychiatry 66(Suppl 2):28-33
22. Furukawa TA, Streiner DL, Young LT (2001) Antidepressant plus benzodiazepine for major depression. Cochrane Database Syst Rev 2:CD001026
23. Pollack MH (1993) Innovative uses of benzodiazepines in psychiatry. Can J Psychiatry 38(Suppl 4):S122-S126
24. Stevens JC, Pollack MH (2005) Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents. J Clin Psychiatry 66(Suppl 2):21-27
25. Rosenbaum JF (2005) Attitudes toward benzodiazepines over the years. J Clin Psychiatry 66(Suppl 2):4-8